Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Industry Awards.
Bora Pharmaceuticals partners with Accord BioPharma to boost UDENYCA production in the US
Bora Pharmaceuticals partners with Accord BioPharma to manufacture pre-filled syringes of UDENYCA at its Baltimore facility, expanding U.S. cancer care supply through advanced aseptic fill/finish capabilities.
Alkermes to acquire Avadel Pharmaceuticals in $2.1B sleep medicine deal
Alkermes to acquire Avadel Pharmaceuticals for $2.1 billion, gaining sleep drug Lumryz and expanding into narcolepsy treatments; deal strengthens position in orexin-based therapies amid competition with Takeda’s oveporexton.
Ireland launches €1.5M project to rebuild native oyster reefs and boost coastal resilience
UCD leads €1.5M BRICONS project to restore Ireland’s native flat oyster reefs, in partnership with ATU, QUB, and TCD, aiming to boost biodiversity and coastal resilience under the Marine Institute’s Marine Research Programme.
Merck KGaA to shutter Arklow site by 2028 as focus shifts to New Cork facility
Merck KGaA to close its Arklow, Ireland plant by 2028, cutting 100 jobs after discontinuing API production, while expanding €150 million filtration manufacturing operations in Cork under MilliporeSigma.
SGS ISL Cork deepens academic collaboration to cultivate future Scientific Leaders
At SGS ISL Cork, the commitment to scientific excellence extends beyond the laboratory. To meet the growing demand for skilled professionals, SGS has strengthened its partnership with University College Cork (UCC) to develop future industry leaders through research and mentoring.
Empowering Ireland’s BioPharmaChem Workforce Through Funded, Industry-Led Training
Ireland’s biopharmaceutical and chemical industries are among the country’s greatest success stories, driving exports, innovation, and high-value employment. Yet sustaining that success depends on one critical factor: a skilled and adaptable workforce.
Biopharma Outlook
The pharma and life sciences industry stands at a pivotal moment, defined by rapid innovation, evolving regulations, and the constant pursuit of excellence. Yet, amid the complexity of scientific advancement, one principle remains clear: progress depends on people. Building a skilled, forward-thinking workforce has become central to sustaining Ireland’s position as a global leader in BioPharmaChem and beyond. Empowering Ireland’s BioPharmaChem Workforce through funded, industry-led training showcases how coordinated investment in education and industry partnerships is reshaping talent pipelines. The initiative reflects a broader commitment to preparing professionals for the next generation of biopharma manufacturing. SGS ISL Cork’s academic collaboration reinforces this vision by nurturing the next wave of scientific leaders through applied research and mentoring. It demonstrates how academia and industry can jointly accelerate innovation. Meanwhile, Alice Redmond’s appointment to the Pharma Industry Awards 2025 Judging Coordinator adds further expertise to a platform that celebrates achievement and drives excellence across the sector. These developments highlight an industry investing deeply in its people, ensuring that Ireland’s leadership in pharma and life sciences continues to grow stronger and more resilient.
Alice Redmond to bring expertise as Judging Coordinator in Pharma Industry Awards 2025
With over 30 years of experience in the pharmaceutical, medical device, and biotechnology sectors, Alice Redmond brings unparalleled expertise and leadership to the judging panel of the Pharma Industry Awards 2025.
Anthropic launches Claude for Life Sciences to accelerate discovery
Anthropic launches Claude for Life Sciences, its first major life science venture, enabling AI-driven research, data analysis, and regulatory drafting to accelerate drug discovery through partnerships with Benchling, PubMed, and 10x Genomics.
Merck trims 2026 outlook as healthcare growth slows
Merck KGaA shares fell 7% after the company issued 2026 guidance projecting low-to-mid single-digit organic sales growth and stable EBITDA, while healthcare sales temporarily moderate. CEO Belen Garijo highlighted life science M&A priorities.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!


Sort by


.png)

